Help Lines 954-785-1121
 


You are not logged in. Upgrade Here
 <<<Previous Mid Day Report     Next Mid Day Report >>> 
 <<<Previous After Market Report Next After Market Report >>> 
You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Tuesday, September 17, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

AFTER MARKET UPDATE - MONDAY, JANUARY 12TH, 2015
Previous After Market Report Next After Market Report >>>
Indices NYSE Nasdaq
DOW  -96.53 17,640.84 -0.54% Volume 758,912,510 +6% Volume 1,728,056,940 +10%
NASDAQ -39.36 4,664.71 -0.84% Advancers 1,163 36% Advancers 1,076 35%
S&P 500 -16.55 2,028.26 -0.81% Decliners 1,939 60% Decliners 1,878 62%
Russell 2000 -5.58 1,180.09 -0.47% 52 Wk Highs 188   52 Wk Highs 82  
S&P 600 -2.86 677.88 -0.42% 52 Wk Lows 148   52 Wk Lows 96  

Indices Fell More Modestly But With Higher Volume Totals

Stocks declined on Monday’s session. The Dow fell 96 points to 17,640. The S&P 500 lost 16 points to 2,028. The NASDAQ Composite retreated 39 points to 4,664. The volume totals on the NYSE and on the Nasdaq exchange were higher than the prior session, a sign of more distributional selling pressure coming from the institutional crowd. Breadth was negative as decliners led advancers by a 3-2 margin on the NYSE and by 9-5 on the Nasdaq exchange.  There were 42 high-ranked companies from the CANSLIM.net Leaders List that made new 52-week highs and appeared on the CANSLIM.net BreakOuts Page, down from the prior session total of 54 stocks. New 52-week highs outnumbered new 52-week lows on the NYSE but new lows outnumbered new highs on the Nasdaq exchange. There were gains for 6 of the 13 high-ranked companies currently on the Featured Stocks Page

The newspaper noted last Thursday's big +1.8% gain from the Nasdaq Composite Index with higher volume as a follow-through day.  Regarding the M criteria of the fact-based investment system, the better action suggested that new buying efforts may be carefully made again in stocks meeting all fundamental and technical guidelines.

 

PICTURED: The Dow Jones Industrial Average fell 96 points to 17,640, closing just below its 50-day moving average (DMA) line.

The major averages finished firmly lower amid continued weakness in oil. NYMEX WTI crude dropped -5.1% to $45.88/barrel attributed to reduced analyst outlooks for the commodity. Chevron (CVX -2.15%) and Schlumberger (SLB -3.90%) were both lower.

Investors also appeared cautious ahead of the start to earnings season. Consensus expectations are S&P 500 profits rose +2% in the fourth quarter versus a projected +8.1% increase in October, according to Bloomberg. Alcoa (AA +0.37%) edged higher before the release of its quarterly results after the close. Lululemon (LULU +6.75%) rallied after raising its guidance. Tiffany (TIF -13.96%) fell after cutting its full-year outlook. SanDisk (SNDK -13.88%) fell on the chipmaker's reduced sales forecast.

The market was also lower despite encouraging news from the health care sector. NPS Pharmaceuticals (NPSP +8.21%) climbed after Shire (SHPG -3.86%) agreed to acquire the company for $5.2 billion. Foundation Medicine (FMI +95.32%) surged on Roche (RHHBY +0.60%) announcing it was taking a majority stake in the diagnostic equipment maker. Bristol-Myers (BMY +3.08%) was higher following positive results of a study for its lung cancer treatment.

Treasuries rose with the 10-year note gaining 11/32 to yield 1.91%. Gold was up +1.4% to $1,233.50/ounce on the COMEX.

Disciplined investors know that new buying efforts should only be made in stocks when all fundamental and technical guidelines are met. This should be done as the stock is breaking out of a sound base pattern. Historic studies have shown that odds are not as favorable for investors when buying stocks on pullbacks. 

The Featured Stocks Page shows recent notes and Headline Links directing members to detailed analysis with data-packed graphs annotated by a Certified expert.  See the Premium Member Homepage for archives to all prior pay reports published.


Kenneth J. Gruneisen started out as a licensed stockbroker in August 1987, a couple of months prior to the historic stock market crash that took the Dow Jones Industrial Average down -22.6% in a single day. He has published daily fact-based fundamental and technical analysis on high-ranked stocks online for two decades. Through FACTBASEDINVESTING.COM, Kenneth provides educational articles, news, market commentary, and other information regarding proven investment systems that work in good times and bad.

Comments contained in the body of this report are technical opinions only and are not necessarily those of Gruneisen Growth Corp. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. Our firm, employees, and customers may effect transactions, including transactions contrary to any recommendation herein, or have positions in the securities mentioned herein or options with respect thereto. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities.


Gold & Silver and Biotech Indexes Rose on Mostly Negative Session

The Gold & Silver Index ($XAU +3.75%) was a standout gainer while most groups ended lower on Monday. The Oil Services Index ($OSX -4.43%) and the Integrated Oil Index ($XOI -3.10%) both suffered big losses. The Semiconductor Index ($SOX -2.00%) and the Networking Index ($NWX -1.37%) both dragged the tech sector lower while the Biotechnology Index ($BTK +1.13%) rose.  The Retail Index ($RLX -0.99%) was a negative influence on the major averages along with financials as the Bank Index ($BKX -1.03%) and the Broker/Dealer Index ($XBD -0.59%) ended lower.

Charts courtesy www.stockcharts.com

PICTURED: The Broker/Dealer Index ($XBD -0.59%) slumped below its 50-day moving average (DMA) line again. Subsequent deterioration below prior lows would be a worrisome sign because the financial groups are considered reliable leading indicators.  


Industry Index Symbol Close Change % Change YTD % Change
Oil Services $OSX  189.72 -8.79 -4.43% -10.03%
Integrated Oil $XOI  1,261.99 -40.38 -3.10% -6.39%
Semiconductor $SOX  671.82 -13.70 -2.00% -2.19%
Networking $NWX  348.83 -4.84 -1.37% -2.54%
Broker/Dealer $XBD  177.63 -1.05 -0.59% -3.80%
Retail $RLX  1,002.01 -10.04 -0.99% -2.97%
Gold & Silver $XAU  79.03 +2.86 +3.75% +14.90%
Bank $BKX  70.18 -0.73 -1.03% -5.49%
Biotech $BTK  3,578.99 +40.05 +1.13% +4.07%


Consolidating Near 50-Day Average After Stalling at 52-Week High

Facebook Inc (FB -$1.02 or -1.31% to $76.72) halted its slide after quietly retreating near its 50-day moving average (DMA) line. Now resistance remains due to overhead supply up through the $82 level. And convincing volume-driven gains above the pivot point are still needed to clinch a proper new (or add-on) technical buy signal. The high-ranked Internet - Content firm was last shown in this FSU section on 12/04/14 with annotated graphs under the headline, "Gains for New Highs Backed By Lighter Volume", as it finished at a new all-time high with a gain on lighter volume. Members were then reminded - "Gains above a pivot point should be backed by a minimum of +40% above average volume to trigger a proper technical buy signal. A new pivot point was cited based on its 10/28/14 high plus 10 cents. No resistance remains due to overhead supply." Disciplined investors wait for fresh proof of heavy institutional buying demand, then buy stocks that are breaking out before they have risen more than +5% above their pivot point.

The company reported earnings +59% on +59% sales revenues for the Sep '14 quarter but warned of rising costs. That marked its 6th consecutive quarterly comparison with earnings increasing well above the +25% minimum (C criteria). The high-ranked Internet - Content group leader has seen the number of top-rated funds owning its shares rise from 1,116 in Dec '12 to 2,443 in Dec '14, a reassuring sign concerning the I criteria. Members were previously warned - "Keep in mind that its large supply of 2.54 billion shares in the public float makes it an unlikely sprinter, especially as it is already well known by the institutional crowd and the general public."

 


Color Codes Explained :
Y - Better candidates highlighted by our staff of experts.
G - Previously featured in past reports as yellow but may no longer be buyable under the guidelines.

***Last / Change / Volume data in this table is the closing quote data***
Symbol/Exchange
Company Name
Industry Group
PRICE CHANGE
(%Change)
Day High Volume
(% DAV)
(% 50 day avg vol)
52 Wk Hi
% From Hi
Featured
Date
Price
Featured
Pivot Featured
Max Buy
ACT - NYSE
Actavis plc
Medical-Generic Drugs  
$272.28 +3.60
1.34%

$275.75

3,118,651
99.83% of 50 DAV
50 DAV is 3,124,000
$272.75
-0.17%
12/29/2014 $260.22 PP = $272.85
MB = $286.49
Most Recent Note - 1/12/2015 6:28:32 PM
Y - Hit a new high today but with only average volume. Found support at its 50 DMA line recently. Subsequent volume-driven gains above the pivot point may trigger a technical buy signal.
>>> FEATURED STOCK ARTICLE : Formed New Base Above Prior Highs and 50-Day Moving Average - 12/29/2014
View all notes | Set NEW NOTE alert | CANSLIM.net Company Profile | SEC News | Chart | Request a new note C A N S L I M   Daily Graphs Online Stock Checkup
AFSI - NASDAQ
Amtrust Financial Svcs
INSURANCE - Property and; Casualty Insurance  
$50.25 -1.59
-3.07%

$51.80

1,106,118
104.65% of 50 DAV
50 DAV is 1,057,000
$59.31
-15.28%
10/17/2014 $45.24 PP = $46.02
MB = $48.32
Most Recent Note - 1/12/2015 6:30:58 PM
G - Down today for a 3rd consecutive loss. Completed a new Public Offering and gapped down on 1/08/15 violating its 50 DMA line with a damaging loss that raised concerns and triggered a technical sell signal.
>>> FEATURED STOCK ARTICLE : Finding Support Near Prior Highs - 12/24/2014
View all notes | Set NEW NOTE alert | CANSLIM.net Company Profile | SEC News | Chart | Request a new note C A N S L I M   Daily Graphs Online Stock Checkup
ALXN - NASDAQ
Alexion Pharmaceuticals
DRUGS - Drug Manufacturers - Other  
$183.36 -0.91
-0.49%

$186.96

752,958
70.04% of 50 DAV
50 DAV is 1,075,000
$203.30
-9.81%
10/23/2014 $184.01 PP = $185.53
MB = $194.81
Most Recent Note - 1/8/2015 12:31:03 PM
G - Concerns remain since it negated the prior technical breakout. Needs gain above its 50 DMA line ($190.29) which may act as resistance while trying to rebound. The recent low ($176.01 on 12/17/14) acted as a support level. Faces resistance due to overhead supply up through the $203 level.
>>> FEATURED STOCK ARTICLE : 50-Day Moving Average Acted as Resistance After Damaging Losses - 1/2/2015
View all notes | Set NEW NOTE alert | CANSLIM.net Company Profile | SEC News | Chart | Request a new note C A N S L I M   Daily Graphs Online Stock Checkup
AMBA - NASDAQ
Ambarella Inc
ELECTRONICS - Semiconductor - Specialized  
$61.90 +0.07
0.11%

$62.90

1,593,216
76.19% of 50 DAV
50 DAV is 2,091,000
$62.82
-1.46%
1/7/2015 $54.96 PP = $58.10
MB = $61.01
Most Recent Note - 1/9/2015 12:01:21 PM
Y - Perched at its 52-week high with today's 4th consecutive volume-driven gain. The volume-driven gain above the pivot point on 1/07/15 triggered a technical buy signal, and more convincing strength returned to the broader market (M criteria) on 1/08/15.
>>> FEATURED STOCK ARTICLE : Strong Finish Triggered a Technical Buy Signal - 1/7/2015
View all notes | Set NEW NOTE alert | CANSLIM.net Company Profile | SEC News | Chart | Request a new note C A N S L I M   Daily Graphs Online Stock Checkup
BIDU - NASDAQ
Baidu Inc Ads
INTERNET - Internet Information Providers  
$220.89 -6.01
-2.65%

$226.50

3,174,942
100.95% of 50 DAV
50 DAV is 3,145,000
$251.99
-12.34%
10/30/2014 $234.08 PP = $231.51
MB = $243.09
Most Recent Note - 1/9/2015 6:41:13 PM
G - Rebounded near its 50 DMA line which may act as resistance. Recent lows in the $216-217 area define important near-term support where subsequent losses would raise more serious concerns. See the latest FSU analysis for more details and new annotated graphs.
>>> FEATURED STOCK ARTICLE : Lingering Below 50-Day Moving Average Line Hurts Outlook - 1/9/2015
View all notes | Set NEW NOTE alert | CANSLIM.net Company Profile | SEC News | Chart | Request a new note C A N S L I M   Daily Graphs Online Stock Checkup
Symbol/Exchange
Company Name
Industry Group
PRICE CHANGE
(%Change)
Day High Volume
(% DAV)
(% 50 day avg vol)
52 Wk Hi
% From Hi
Featured
Date
Price
Featured
Pivot Featured
Max Buy
EPAM - NYSE
Epam Systems Inc
COMPUTER SOFTWARE and SERVICES - Information Technology Service  
$47.75 -0.59
-1.22%

$48.33

204,932
50.11% of 50 DAV
50 DAV is 409,000
$52.89
-9.72%
10/23/2014 $45.21 PP = $46.09
MB = $48.39
Most Recent Note - 1/8/2015 1:47:45 PM
G - Rebounding near its 50 DMA line with today's 3rd consecutive gain. Subsequent losses below its recent low close ($46.24 on 12/16/14) would raise concerns and trigger a more worrisome technical sell signal.
>>> FEATURED STOCK ARTICLE : Halted Slide at 50-Day Moving Average - 12/31/2014
View all notes | Set NEW NOTE alert | CANSLIM.net Company Profile | SEC News | Chart | Request a new note C A N S L I M   Daily Graphs Online Stock Checkup
FB - NASDAQ
Facebook Inc Cl A
INTERNET  
$76.72 -1.02
-1.31%

$78.00

19,150,892
68.45% of 50 DAV
50 DAV is 27,976,000
$82.17
-6.63%
12/22/2014 $81.79 PP = $81.26
MB = $85.32
Most Recent Note - 1/12/2015 6:26:48 PM
Y - Consolidating near its 50 DMA line with volume totals cooling. Resistance remains due to overhead supply up through the $82 level.Volume-driven gains above the pivot point are still needed to clinch a proper new (or add-on) technical buy signal. See the latest FSU analysis for more details and new annotated graphs.
>>> FEATURED STOCK ARTICLE : Consolidating Near 50-Day Average After Stalling at 52-Week High - 1/12/2015
View all notes | Set NEW NOTE alert | CANSLIM.net Company Profile | SEC News | Chart | Request a new note C A N S L I M   Daily Graphs Online Stock Checkup
ILMN - NASDAQ
Illumina Inc
DRUGS - Biotechnology  
$190.10 -4.70
-2.41%

$198.75

3,058,232
289.06% of 50 DAV
50 DAV is 1,058,000
$199.48
-4.70%
12/30/2014 $186.26 PP = $196.00
MB = $205.80
Most Recent Note - 1/12/2015 6:38:06 PM
Y - Down today with triple average volume, action indicative of distributional pressure. It stalled after last week's rally from a "double bottom" base with volume-driven gains.
>>> FEATURED STOCK ARTICLE : Forming New Base And Fundamentals Remain Favorable - 12/30/2014
View all notes | Set NEW NOTE alert | CANSLIM.net Company Profile | SEC News | Chart | Request a new note C A N S L I M   Daily Graphs Online Stock Checkup
NXPI - NASDAQ
Nxp Semiconductors N V
ELECTRONICS - Semiconductor - Broad Line  
$80.35 +0.03
0.04%

$81.29

2,926,204
95.16% of 50 DAV
50 DAV is 3,075,000
$80.97
-0.77%
1/5/2015 $76.43 PP = $78.44
MB = $82.36
Most Recent Note - 1/9/2015 12:29:13 PM
Y - Hitting a new 52-week high with today's 3rd consecutive gain after finding prompt support at its 50 DMA line. Strength returned to the broader market (M criteria) on 1/08/15. Gains above the pivot point backed by at least +40% above average volume may clinch a convincing new technical buy signal.
>>> FEATURED STOCK ARTICLE : Little Resistance Remains Due to Overhead Supply - 1/5/2015
View all notes | Set NEW NOTE alert | CANSLIM.net Company Profile | SEC News | Chart | Request a new note C A N S L I M   Daily Graphs Online Stock Checkup
PANW - NYSE
Palo Alto Networks
Computer Sftwr-Security  
$127.28 +1.46
1.16%

$128.03

875,723
61.28% of 50 DAV
50 DAV is 1,429,000
$129.42
-1.66%
7/30/2014 $84.21 PP = $85.88
MB = $90.17
Most Recent Note - 1/8/2015 6:07:45 PM
G - Posted a 2nd consecutive gain today with even lighter volume. Prior reports cautioned members - "It has not formed a sound base. The 50 DMA line defines near-term support to watch below recent lows." See the latest FSU analysis for more details and new annotated graphs.
>>> FEATURED STOCK ARTICLE : Tech Firm Still Extended From Any Sound Base Pattern - 1/8/2015
View all notes | Set NEW NOTE alert | CANSLIM.net Company Profile | SEC News | Chart | Request a new note C A N S L I M   Daily Graphs Online Stock Checkup
Symbol/Exchange
Company Name
Industry Group
PRICE CHANGE
(%Change)
Day High Volume
(% DAV)
(% 50 day avg vol)
52 Wk Hi
% From Hi
Featured
Date
Price
Featured
Pivot Featured
Max Buy
RH - NYSE
Restoration Hardware Hld
RETAIL - Home Furnishing Stores  
$94.14 +0.52
0.56%

$95.29

554,954
61.19% of 50 DAV
50 DAV is 907,000
$100.66
-6.48%
12/11/2014 $98.66 PP = $94.60
MB = $99.33
Most Recent Note - 1/12/2015 6:33:55 PM
Y - Still sputtering with volume totals cooling after recent losses negated the prior breakout and raised concerns. Its 50 DMA line defines the next support level to watch.
>>> FEATURED STOCK ARTICLE : Consolidating Above Prior Highs With Volume Totals Cooling - 12/26/2014
View all notes | Set NEW NOTE alert | CANSLIM.net Company Profile | SEC News | Chart | Request a new note C A N S L I M   Daily Graphs Online Stock Checkup
UIHC - NASDAQ
United Insurance Holding
Insurance-Prop/Cas/Titl  
$21.49 -0.19
-0.88%

$21.67

184,843
85.58% of 50 DAV
50 DAV is 216,000
$22.44
-4.23%
12/5/2014 $20.64 PP = $20.31
MB = $21.33
Most Recent Note - 1/8/2015 1:50:33 PM
G - There was a "negative reversal" after touching a new 52-week high on 1/02/15. Color code is changed to green after inching back above its "max buy" level with a quiet gain. Prior highs and its 50 DMA line ($19.87) define near-term support to watch.
>>> FEATURED STOCK ARTICLE : Recent Streak of Gains Lacked Volume Conviction - 12/23/2014
View all notes | Set NEW NOTE alert | CANSLIM.net Company Profile | SEC News | Chart | Request a new note C A N S L I M   Daily Graphs Online Stock Checkup
VRX - NYSE
Valeant Pharmaceuticals
DRUGS - Drug Manufacturers - Other  
$155.50 +1.92
1.25%

$155.56

2,530,041
118.67% of 50 DAV
50 DAV is 2,132,000
$156.60
-0.70%
1/5/2015 $144.84 PP = $149.90
MB = $157.40
Most Recent Note - 1/8/2015 1:24:47 PM
Y - Gapped up today hitting new 52-week and all-time highs with a considerable volume-driven gain, rallying above the new pivot point and triggering a technical buy signal. Went through a deep consolidation below its 200 DMA line then rebounded since dropped from the Featured Stocks list on 4/04/14. See the latest FSU analysis for more details and an annotated daily graph.

>>> FEATURED STOCK ARTICLE : Formed a Big Cup-With-Handle Base Setup - 1/6/2015
View all notes | Set NEW NOTE alert | CANSLIM.net Company Profile | SEC News | Chart | Request a new note C A N S L I M   Daily Graphs Online Stock Checkup

THESE ARE NOT BUY RECOMMENDATIONS!  Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. This site is not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time.  Questions or comments may be submitted by writing to Premium Membership Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 1-800-965-8307 or 954-785-1121.

Kenneth J. Gruneisen founded Gruneisen Growth Corp. (2003), which prior to May 11, 2015, operated CANSLIM.net and CANSLIM.com both under license from Data Analysis Inc. / Investor's Business Daily. Kenneth has passed the CAN SLIM® Master's Exam. Gruneisen Growth Corp. now continues over two decades of fact based market analysis via FactBasedInvesting.com.

Copyright © 1996-2024 Gruneisen Growth Corp. All rights reserved. Protected by the copyright laws of the United States and Canada and by international treaties

Privacy Policy | Terms of Use | Contact Us